In Vitro and In Silico Anticyclooxygenase and Antitopoisomerase Activity of Anonna cherimola Ent-Kaurenes
Annona cherimola is noted for its bioactive compounds, particularly diterpenes called ent-kaurenes, which exhibit various biological activities. This study focused on evaluating the ability of ent-kaurenes from Annona cherimola to inhibit cyclooxygenase (COX) and topoisomerase (TOP) enzymes. Researchers used solvent-free lipophilic eluates (SFLEs) from the plant in enzymatic assays and a yeast model. The major compounds in SFLE were identified using gas chromatography–mass spectrometry (GC-MS), and in silico studies explored their inhibition mechanisms. SFLE showed significant inhibition of COX-II (95.44%) and COX-I (75.78%) enzymes and fully inhibited the yeast strain. The effectiveness of inhibition is attributed to the compounds’ structural diversity, lipophilicity, and molecular weight. Two main compounds, kauran-16-ol and isopimaral, were identified, with in silico results suggesting that they inhibit COX-II by blocking peroxidase activity and COX-I by interacting with the membrane-binding region. Additionally, these compounds allosterically and synergistically inhibit TOP-II and potentially sensitize cancer cells by interacting with key amino acids. This research is the first to identify and evaluate kauran-16-ol and isopimaral in silico, suggesting their potential as anti-inflammatory and anticancer agents.
Authors
- Jorge Alberto Sánchez-Burgos (ORCID: https://orcid.org/0000-0003-2295-7404)
- Carlos Eduardo Camacho-González
- Alejandro Pérez‐Larios (ORCID: https://orcid.org/0000-0001-8656-5667)
- Sonia G. Sáyago‐Ayerdi (ORCID: https://orcid.org/0000-0002-4430-1273)
- Jasmin Salazar-Mendoza
Institutions
- Universidad de Guadalajara (MX)
- Tecnológico Nacional de México (MX)
- Instituto Tecnológico de Tepic (MX)
Publication Details
- Journal
- Separations
- Published
- 2024-09-06
- DOI
- https://doi.org/10.3390/separations11090263
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 0.00